Z4K-20384-15591
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-24
Registered in v-safe
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-25
- 2021-03-26
-
2021-11-07
Dose 2 — Moderna
-
2021-11-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-11-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-11-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-21
-
2022-05-08
Survey response — 6 months, dose 2MedDRA: COVID-19, Pregnancy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pregnancy, COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-09
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-08 | Successful 2022-05-09 |
Not applicable - Accidental Reporting |
Free text
Release 11 — 6 months, dose 2
Symptoms: Pregnancy, COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release